FLT3 directed car cells for immunotherapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10961312
APP PUB NO 20180118838A1
SERIAL NO

15811608

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

CAR cells targeting FLT3 relevant antigens are described as a new method of cancer treatment. It is proposed that FLT3 CAR cells are safe and effective in patients and can be used to treat human tumors and cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CYTOIMMUNE THERAPEUTICS INCCORPORATION SERVICE COMPANY 251 LITTLE FALLS DRIVE WILMINGTON DE 19808

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Caligiuri, Michael Columbus, US 12 38
Devine, Steven Columbus, US 3 5
Yu, Jianhua Columbus, US 45 68

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 30, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 30, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00